martes, 11 de noviembre de 2014

National Guideline Clearinghouse | Prevention and treatment of rash in patients treated with EGFR inhibitor therapies.

full-text ►

National Guideline Clearinghouse | Prevention and treatment of rash in patients treated with EGFR inhibitor therapies.



CancerControl Alberta

National Guideline Clearinghouse (NGC)

Guideline Title
Prevention and treatment of rash in patients treated with EGFR inhibitor therapies.
Bibliographic Source(s)
Alberta Provincial Thoracic Malignancies Team, Alberta Provincial Gastrointestinal Tumour Team, Alberta Provincial Head and Neck Tumour Team. Prevention and treatment of rash in patients treated with EGFR inhibitor therapies. Edmonton (Alberta): CancerControl Alberta; 2012 May. 15 p. (Clinical practice guideline; no. SUPP-003).  [73 references]
Guideline Status
This is the current release of the guideline.

No hay comentarios:

Publicar un comentario